Transcriptional networks that control the development of organisms are precise, highly coordinated, and complex. This proposal seeks to understand how the same transcription factor can specify multiple distinct cell fates during the development of an organism. Specifically, we are interested in the transcription factor Olig2, which can promote both a motoneuron and an oligodendrocyte cell fate. We hypothesize that Olig2 is able to perform its multiple functions through interactions with other DNA binding proteins causing it to bind different targets in different cellular contexts. Testing this hypothesis using current methods for the analysis of transcription factors is difficult because they cannot trace binding throughout a cell lineage, making it impossible to correlate DNA-binding events in progenitor cells to the final cell fates of their progeny. We propose to use a novel method, transposon """"""""Calling Cards"""""""", to record Olig2 binding during neural differentiation. The method entails fusing the transposase of a transposon to a transcription factor, thereby causing it to direct the insertion of transposon DNA into the genome near where it binds. The transposon becomes a """"""""Calling Card"""""""" that permanently marks the transcription factor's visit to that place in the genome. By recovering these Calling Cards along with some of the genomic DNA that flanks them and then determining their DNA sequences, it is possible to map the genome-wide binding history of the transcription factor. We propose to apply the Calling Card method to understand how Olig2 carries out its distinct functions. Since many important transcription factors perform more than one function during development, the insights that we gain from this work should be broadly applicable.
Our specific aims are 1) to trace Olig2 binding through neural stem cell differentiation to understand how it promotes two distinct cell fates, 2) to confirm that differentially bound target genes promote motoneuron or oligodendrocyte cell fates, 3) to analyze Olig2 and Ngn2 binding in living zebrafish using Calling Card technology.
These aims are feasible: we have successfully implemented the Calling Card method in both yeast and mammalian cells, and our preliminary results demonstrate transcription factor directed insertion of Calling Cards in zebrafish. We are confident that the rewards of further developing this technology and applying it to understand the process of cell fate specification will be substantial

Public Health Relevance

For neurons to properly function, they must be coated with an insulating material called myelin. The cells that produce and maintain myelin are called oligodendrocytes, and if they are damaged or compromised, the nervous system becomes impaired, causing diseases like multiple sclerosis. One possible way to treat diseases caused by myelin loss is to differentiate stems cells to generate oligodendrocytes or their precursors. These cells could then be used to replace the dysfunctional oligodendrocytes. However, we are not yet facile at controlling stem cell differentiation. This proposal seeks to understand the mechanism by which stem cells differentiate into oligodendrocytes using a novel method that will allow us to analyze this process in a way that has not previously been possible. It is our hope that a better understanding of oligodendrocyte differentiation will ultimately translate into stem cell based treatments for demyelinating diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS076993-03
Application #
8686973
Study Section
Genomics, Computational Biology and Technology Study Section (GCAT)
Program Officer
Lavaute, Timothy M
Project Start
2012-07-15
Project End
2017-06-30
Budget Start
2014-07-01
Budget End
2015-06-30
Support Year
3
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Washington University
Department
Genetics
Type
Schools of Medicine
DUNS #
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Liu, Chang; Xiao, Fangzhou; Hoisington-Lopez, Jessica et al. (2018) Accurate Typing of Human Leukocyte Antigen Class I Genes by Oxford Nanopore Sequencing. J Mol Diagn 20:428-435
Mayhew, David; Mitra, Robi D (2016) Transposon Calling Cards. Cold Spring Harb Protoc 2016:pdb.top077776
Haller, Gabe; Alvarado, David; McCall, Kevin et al. (2016) Massively parallel single-nucleotide mutagenesis using reversibly terminated inosine. Nat Methods 13:923-924
Yu, Haiyang; Artomov, Mykyta; Brähler, Sebastian et al. (2016) A role for genetic susceptibility in sporadic focal segmental glomerulosclerosis. J Clin Invest 126:1067-78
Schillebeeckx, Maximiliaan; Pihlajoki, Marjut; Gretzinger, Elisabeth et al. (2015) Novel markers of gonadectomy-induced adrenocortical neoplasia in the mouse and ferret. Mol Cell Endocrinol 399:122-30
Röhrig, Theresa; Pihlajoki, Marjut; Ziegler, Ricarda et al. (2015) Toying with fate: Redirecting the differentiation of adrenocortical progenitor cells into gonadal-like tissue. Mol Cell Endocrinol 408:165-77
Zhang, Chi; Myers, Connie A; Qi, Zongtai et al. (2015) Redesign of the monomer-monomer interface of Cre recombinase yields an obligate heterotetrameric complex. Nucleic Acids Res 43:9076-85
Bien-Willner, Gabriel A; Mitra, Robi D (2014) Mutation and expression analysis in medulloblastoma yields prognostic variants and a putative mechanism of disease for i17q tumors. Acta Neuropathol Commun 2:74
Mayhew, David; Mitra, Robi D (2014) Transcription factor regulation and chromosome dynamics during pseudohyphal growth. Mol Biol Cell 25:2669-76
Brooks, Michael D; Jackson, Erin; Warrington, Nicole M et al. (2014) PDE7B is a novel, prognostically significant mediator of glioblastoma growth whose expression is regulated by endothelial cells. PLoS One 9:e107397

Showing the most recent 10 out of 13 publications